Table 1 STOPP criteria that were not assessed in the LiLACS NZ study

 Aspirin with a past history of peptic ulcer disease without histamine H₂ receptor antagonist or Proton Pump Inhibitor

Peptic Ulcer Disease was recorded only if an active condition i.e. history was not investigated

 Warfarin for first, uncomplicated deep venous thrombosis for longer than 6 months

Reason for treatment with warfarin was not documented

 Warfarin for first uncomplicated pulmonary embolus for longer than 12 months duration

Reason for treatment with warfarin was not documented

 Aspirin, clopidogrel, dipyridamole or warfarin with concurrent bleeding disorder

Presence of bleeding disorder was not recorded

 TCA’s with prostatism or prior history of urinary retention

History of urinary retention

 Long-term (i.e. >  1 month) neuroleptics as long-term hypnotics

Indication for neuroleptics was not documented

 Selective serotonin re-uptake inhibitors (SSRI’s) with a history of clinically significant hyponatraemia

Hyponatraemia was noted if present, but not if patients had a history of it

 Diphenoxylate, loperamide or codeine phosphate for treatment of diarrhoea of unknown cause

Diarrhoea as an indication was not recorded

 Diphenoxylate, loperamide or codeine phosphate for treatment of severe infective gastroenteritis

Gastroenteritis as an indication was not recorded

 Non-steroidal anti-inflammatory drug (NSAID) with history of peptic ulcer disease or gastrointestinal bleeding, unless with concurrent histamine H₂ receptor antagonist, PPI or misoprostol

Peptic Ulcer Disease was recorded only if an active condition i.e. history was not investigated

 Alpha-blockers in males with frequent incontinence i.e. one or more episodes of incontinence daily

Presence of incontinence was not recorded

 Alpha-blockers with long-term urinary catheter in situ i.e. more than 2 months

Presence of a catheter was not recorded